I think this is their way of testing the waters in the OTC business.
They are throwing one of their existing products with predefined generic settings into the OTC market.
Reduced settings, access to programmability locked.
The development costs have already been incurred, the product is in mass production. Actual manufacturing costs are very, very low.
I’m also very curious to hear what you find out when you receive the devices.
Keep us posted, please .